Clal Biotechnology Industries (XTAE:CBI) Total Liabilities : ₪36.98 Mil (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Clal Biotechnology Industries Total Liabilities?

Clal Biotechnology Industries's Total Liabilities for the quarter that ended in Dec. 2023 was ₪36.98 Mil.

Clal Biotechnology Industries's quarterly Total Liabilities increased from Dec. 2022 (₪37.79 Mil) to Jun. 2023 (₪40.99 Mil) but then declined from Jun. 2023 (₪40.99 Mil) to Dec. 2023 (₪36.98 Mil).

Clal Biotechnology Industries's annual Total Liabilities declined from Dec. 2021 (₪106.55 Mil) to Dec. 2022 (₪37.79 Mil) and declined from Dec. 2022 (₪37.79 Mil) to Dec. 2023 (₪36.98 Mil).

Clal Biotechnology Industries Total Liabilities Historical Data

The historical data trend for Clal Biotechnology Industries's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clal Biotechnology Industries Total Liabilities Chart

Clal Biotechnology Industries Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

119.12

100.24

106.55

37.79

36.98

Clal Biotechnology Industries Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial															115.06	38.19	37.79	40.99	36.98

Clal Biotechnology Industries Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Clal Biotechnology Industries's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	6.662	+	(30.316	+	3.5527136788005E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	36.98

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	158.386	-	121.408
	=	36.98

Clal Biotechnology Industries's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	6.662	+	(30.316	+	3.5527136788005E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	36.98

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	158.386	-	121.408
	=	36.98

Clal Biotechnology Industries Total Liabilities Related Terms

Thank you for viewing the detailed overview of Clal Biotechnology Industries's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Clal Biotechnology Industries (XTAE:CBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clal Biotechnology Industries Ltd (XTAE:CBI) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Azrieli Center, Triangle Building, 45th Floor, Tel Aviv, ISR, 67023

Website

http://www.cbi.co.il

Clal Biotechnology Industries Ltd is a life sciences investment company. The company invests in companies ranging from seed to maturity, both public and private. Its portfolio of investments includes from heavy industry to biotechnology, hi-tech and energy companies.